Mong Lin

Mong Lin is a Scientist at Pfizer, where they have been contributing since 2023. Previously, they held various roles in research and quality control, including positions at Seagen, the Infectious Disease Research Institute, and Dharma Therapeutics, Inc. They also gained experience as a Research Associate at Xcyte Therapies and ID Biomedical, and as a Quality Control Chemist at Bio-Rad Laboratories. Mong Lin began their career in drug metabolism research at ICOS Corporation.